Logo

    ./

    Description

    Ciflafin-TZ Tablets represent an advanced pharmaceutical solution combining ciprofloxacin 500mg and tinidazole 600mg in a single formulation. This powerful combination therapy effe...
    Ciflafin-TZ Tablets represent an advanced pharmaceutical solution combining ciprofloxacin 500mg and tinidazole 600mg in a single formulation. This powerful combination therapy effectively addresses complex infections where both bacterial and parasitic organisms are present. Manufactured under stringent quality control protocols, each tablet ensures precise dosage delivery and consistent therapeutic outcomes. The formulation leverages ciprofloxacin's bactericidal action against aerobic pathogens alongside tinidazole's effectiveness against anaerobic bacteria and protozoa. This dual-mechanism approach provides comprehensive coverage for mixed infections that single-antibiotic therapies cannot adequately treat. Our production process maintains pharmaceutical-grade standards from raw material selection through final packaging, ensuring complete product integrity and patient safety.
    
    The healthcare industry utilizes Ciflafin-TZ Tablets across multiple medical specialties including gastroenterology, urology, surgery, and gynecology. Hospitals and clinics employ this combination therapy for treating complicated intra-abdominal infections, pelvic inflammatory disease, and surgical site infections where multiple pathogens are suspected. Medical professionals in emergency departments value its broad-spectrum coverage for empirical treatment while awaiting laboratory culture results. The tablets are particularly essential in regions with high prevalence of parasitic infections, providing reliable treatment for amoebic dysentery and giardiasis. Healthcare institutions maintain this medication in their formularies for its versatility in managing diverse infection scenarios and reducing the need for multiple separate prescriptions.
    
    Business partners benefit from our commitment to pharmaceutical excellence and supply chain reliability. We maintain consistent inventory levels and accommodate various order quantities to meet fluctuating demand patterns from hospitals, distributors, and healthcare providers. Our manufacturing facilities strictly adhere to international quality standards, ensuring every batch meets precise specifications for potency and purity. The tablets' proven clinical effectiveness builds confidence among medical professionals, supporting your business growth through repeat orders and professional recommendations. Our responsive customer service team ensures smooth transactions and timely resolution of inquiries, establishing us as your dependable partner in pharmaceutical sourcing.
    
    Key Features:
    - Precise combination of ciprofloxacin 500mg and tinidazole 600mg
    - Manufactured under strict pharmaceutical quality control standards
    - Hygienic blister packaging ensuring product integrity and shelf life
    - Consistent formulation batch-to-batch for reliable therapeutic outcomes
    - Comprehensive documentation including manufacturing and quality certificates
    
    Benefits:
    - Effective treatment for mixed bacterial and parasitic infections
    - Reduced need for multiple medications simplifying patient compliance
    - Trusted by medical professionals for consistent clinical results
    - Flexible order quantities accommodating various business needs
    - Reliable supply chain ensuring consistent product availability

    Specifications

    Additional Information
    Country of Origin106
    CustomisableNo

    Application

    Ciflafin-TZ Tablets provide comprehensive treatment for complex infections requiring dual-action therapy. The combination of ciprofloxacin and tinidazole delivers broad-spectrum coverage against both aerobic bacteria and anaerobic protozoa, making it ideal for gastrointestinal, genitourinary, and surgical infection scenarios where multiple pathogens are involved.
    
    These tablets are particularly valuable in clinical environments where patients present with mixed infections needing thorough antimicrobial coverage. The balanced formulation ensures optimal bioavailability and therapeutic effectiveness while maintaining strict safety standards. Healthcare professionals trust this combination therapy for consistent results across various medical settings and challenging infection cases.
    - Treating complicated gastrointestinal infections including traveler's diarrhea and amoebiasis
    - Managing genitourinary tract infections with mixed bacterial and parasitic involvement
    - Post-surgical infection prevention and treatment in hospital environments
    - Addressing dental infections containing anaerobic bacterial components
    - Managing gynecological infections requiring broad-spectrum antimicrobial coverage

    Trade Details

    Available StockIn stock
    Sample AvailabilityNo

    Payment Terms

    Payment Terms
    • Cash on Delivery (COD, if applicable)

    Company Profile

    Alphine Pharmaceuticals, Andhra Pradesh
    IndiaAndhra Pradesh, India
    Health & Personal CareManufacturerTrading CompanyDistributor / Wholesaler
    Factory Details
    Factory SizeBelow 1000 sqm
    Annual Production Capacity0
    Main Markets
    Domestic

    Ciflafin TZ Tablets Ciprofloxacin 500mg Tinidazole 600mg Infection Treatment

    Ciflafin TZ Tablets combine ciprofloxacin 500mg and tinidazole 600mg for powerful bacterial and parasitic infection treatment. Manufactured under strict quality control for guaranteed reliability and effectiveness in medical applications.

    Min. Order Quantity: 1 Pieces

    Shipping

    Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

    Alphine Pharmaceuticals
    Verified
    IndiaAndhra Pradesh, India
    Health & Personal CareManufacturer

    More Products From Supplier